Oxford Haemophilia

Jun 20, 2024 | emj.bmj.com | Ross Davenport |Nicola Curry |Oxford Haemophilia

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

May 23, 2024 | emj.bmj.com | Ross Davenport |Nicola Curry |Oxford Haemophilia

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Jun 23, 2023 | link.springer.com | Hospitals Birmingham |Oxford Haemophilia

AbstractIntroductionThe current study describes real-world clinical outcomes and factor usage among patients with haemophilia B switching from standard half-life factor IX (SHL FIX) treatment to recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis in European treatment centres. MethodsThis non-interventional, retrospective, multicentre chart review evaluated medical records from adult and paediatric patients with haemophilia B in Denmark, Germany and the UK.